Frank Christian

Dr. Frank Christian


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2016 in Cells
Verified
Journal Article
Open access
PDF file
FCFrank Christian
Frank Christian
ESEmma L. Smith
Emma L. Smith
Ruaidhri CarmodyRuaidhri Carmody
Ruaidhri Carmody
The NF-κB transcription factor is the master regulator of the inflammatory response and is essential for the homeostasis of the immune system. NF-κB regulates the transcription of genes that control inflammation, immune cell development, cell cycle, proliferation, and cell death. The fundamental role that NF-κB plays in key physiological processes makes it an important factor in determining health and disease. The importance of NF-κB in tissue homeostasis and immunity has frustrated therapeutic approaches aimed at inhibiting NF-κB activation. However, significant research efforts have revealed the crucial contribution of NF-κB phosphorylation to controlling NF-κB directed transactivation. Importantly, NF-κB phosphorylation controls transcription in a gene-specific manner, offering new opportunities to selectively target NF-κB for therapeutic benefit. This review will focus on the phosphorylation of the NF-κB subunits and the impact on NF-κB function.

1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FCFrank Christian
Frank Christian
MSMárta Szaszák
Márta Szaszák
SFSabine Friedl
Sabine Friedl
SDStephan Drewianka
Stephan Drewianka
DLDorothea Lorenz
Dorothea Lorenz
Enno KlussmannEnno Klussmann
Enno Klussmann
A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3′-diamino-4,4′-dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMP-API-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.

1 May 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
YSY.Y. Sin
Y.Y. Sin
HEH.V. Edwards
H.V. Edwards
XLX. Li
X. Li
JDJ.P. Day
J.P. Day
FCFrank Christian
Frank Christian
GBGeorge Baillie
George Baillie

1 November 2011 in Molecular Cell
Verified
Journal Article
Closed access
NMNatacha Le Moan
Natacha Le Moan
DHDaniel M. Houslay
Daniel M. Houslay
FCFrank Christian
Frank Christian
MHMiles Houslay
Miles Houslay
KAKaterina Akassoglou
Katerina Akassoglou

18 March 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KBKim M. Brown
Kim M. Brown
JDJon P. Day
Jon P. Day
EHElaine Huston
Elaine Huston
BZBastian Zimmermann
Bastian Zimmermann
KHKornelia Hampel
Kornelia Hampel
GBGeorge Baillie
George Baillie
V-raf-1 murine leukemia viral oncogene homolog 1 (Raf-1) is a key activator of the ERK pathway and is a target for cross-regulation of this pathway by the cAMP signaling system. The cAMP-activated protein kinase, PKA, inhibits Raf-1 by phosphorylation on S259. Here, we show that the cAMP-degrading phosphodiesterase-8A (PDE8A) associates with Raf-1 to protect it from inhibitory phosphorylation by PKA, thereby enhancing Raf-1’s ability to stimulate ERK signaling. PDE8A binds to Raf-1 with high (picomolar) affinity. Mapping of the interaction domain on PDE8A using peptide array technology identified amino acids 454–465 as the main binding site, which could be disrupted by mutation. A cell-permeable peptide corresponding to this region disrupted the PDE8A/Raf-1 interaction in cells, thereby reducing ERK activation and the cellular response to EGF. Overexpression of a catalytically inactive PDE8A in cells displayed a dominant negative phenotype on ERK activation. These effects were recapitulated at the organism level in genetically modified (PDE8A−/−) mice. Similarly, PDE8 deletion in Drosophila melanogaster reduced basal ERK activation and sensitized flies to stress-induced death. We propose that PDE8A is a physiological regulator of Raf-1 signaling in some cells. Significance The ERK pathway is a ubiquitous mechanism for transducing a variety of extracellular signals into intracellular events. It also is misregulated in a number of different disease states including several cancers. The ERK pathway crosstalks with other signaling cascades, including the cAMP system. In this paper, we show that a key component of the ERK pathway, Raf-1 kinase, can associate with a specific cyclic nucleotide phosphodiesterase, phosphodiesterase 8A (PDE8A), to modulate the activity of the kinase. We report that the interaction between Raf-1 and PDE8A underpins functional consequences of ERK signaling in several different model systems.

1 April 2008 in Cellular Signalling
Verified
Journal Article
Closed access
MSMárta Szaszák
Márta Szaszák
FCFrank Christian
Frank Christian
WRWalter Rosenthal
Walter Rosenthal
EKEnno Klussmann
Enno Klussmann